Delivery Order SPE2DB24D6044-SPE2DB25FLJGF
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on August 25, 2025, to supply Naloxone 4 mg/10 mL vials with a ceiling value of $9,855.31 and a firm fixed price contract type. The order was completed as a child delivery order under a larger indefinite delivery contract vehicle with an ultimate completion date of August 26, 2025. This non-competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Naloxone Hydrochloride with a ceiling value of $1,211.66. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $2,093.64 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Naloxone 0.4 mg/mL in vial format. The contract, which represents no set-aside designation, is scheduled for completion by June 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,018.53 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Naloxone 0.4 mg/mL vials. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 0.4 mg/ml vials, with a contract ceiling value of $2,310.50. This firm fixed-price delivery order, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,120.08 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Naloxone 1ML in quantities of 10 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,053.07 and an ultimate completion date of August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 4 mg/10 mL vials on July 11, 2025, with a contract ceiling value of $10,276.45. This firm fixed price delivery order, with an ultimate completion date of July 14, 2025, represents a competitively awarded non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The work will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-count units) with a ceiling value of $1,499.40 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that serves as a comprehensive global...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Naloxone Hydrochloride with a ceiling value of $4,330.94. This is a firm fixed-price, non-set-aside contract with a completion date of September 25, 2025, and will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJGFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,444.42. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The contract contains no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively selected to fulfill this pharmaceutical supply requirement. The delivery order exemplifies the company's role as a pharmaceutical prime vendor supporting military healthcare systems and the Defense Health Agency through DLA's comprehensive global pharmaceutical support program. This transaction is one of numerous competitively awarded delivery orders the contractor fulfills under its prime IDC, which enables the supply of a wide range of pharmaceutical products and medical supplies to support U.S. military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/1/25 |